The Precision in Drug Discovery & Preclinical Summit Boston is dedicated to Research and Development.
The Precision in Drug Discovery & Preclinical Summit Boston covers topics such as:
- Biomarker Discovery & Validation
- Target Discovery and Drug Screening
- Chemical biology, Target Identification & Validation
- Preclinical strategies, models & tools in therapies
- Next Generation Sequencing
- Practical PK PD Modelling in Drug Discovery & Development; better faster and cheaper
- CNS Targets & Translational Strategies
- Small Molecules for Immuno-Oncology & Multiple Therapeutics
- Protein Identification
- Animal Models & Assay Development
- Medicinal Chemistry
- HTS Technology & Antibody Engineering
- Digital Imaging Technology
- DNA Sequencing Services
- Structural Biology
- Lead Optimization and Profiling. HTS Technologies
- Gene/Cell Therapy
- Plant & Animal Made Pharmaceuticals
- Genomics/Genetics
- Bioinformatics
- Medical Devices
- Biomanufacturing
- Nanotechnology
- Cell Biology
- Platform Technologies
- Clinical Research & Lab Services
- Stem Cell Research
- Chemistry
- Tech Transfer
- Drug Delivery
The Precision in Drug Discovery & Preclinical Summit Boston brings together:
- CSO
- CEO
- Senior Director Functional Genomics
- Director Discovery Alliances
- VP Target Discovery & Assessment
- VP of Chemistry
- VP Pharmacology & Preclinical PK/PD
- Senior Director Discovery Research
- Director of Discovery Strategy Portfolio
- Principal Scientist
- Head Pharmacology & Toxicology
- Chief Operating Officer
- Head of Drug Design
- Executive Director Chemistry
- Head of R&D Licensing
- VP Translational Medicine
